Linike Medical Group Ltd
Linike Medical Group Ltd. engages in the renewable energy business. The company is involved in the creation of a solar farm in India. It also focuses on commercial real estate development business. The company was formerly known as Litian Group Inc. and changed its name to Linike Medical Group Ltd. in August 2021. Linike Medical Group Ltd. is based in Calgary, Canada.
Linike Medical Group Ltd (LNMG) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of January 2025: -0.013x
Based on the latest financial reports, Linike Medical Group Ltd (LNMG) has a cash flow conversion efficiency ratio of -0.013x as of January 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-493.55K) by net assets ($37.26 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Linike Medical Group Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Linike Medical Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Linike Medical Group Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Linike Medical Group Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pennexx Foods Inc
PINK:PNNX
|
0.042x |
|
Adynxx Inc
PINK:ADYX
|
0.049x |
|
VNTAD
PINK:VNTAD
|
N/A |
|
BlockQuarry Corp
PINK:BLQC
|
0.003x |
|
Chrysalis Investments Ltd
LSE:CHRY
|
-0.006x |
|
SINO-OCEAN LAND
MU:3SD
|
N/A |
|
Bluefield Solar Income Fund
LSE:BSIF
|
-0.001x |
|
Foresight Solar & Techn VCT PLC Foresight Williams Tech Shares
LSE:FWT
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Linike Medical Group Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Linike Medical Group Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-10-31 | $34.90 Million | $-766.55K | -0.022x | +65.80% |
| 2023-10-31 | $35.14 Million | $-2.26 Million | -0.064x | -125.25% |
| 2022-10-31 | $-75.27K | $-19.15K | 0.254x | -44.38% |
| 2021-10-31 | $-48.13K | $-22.01K | 0.457x | -59.88% |
| 2020-10-31 | $-18.27K | $-20.82K | 1.140x | +1823.73% |
| 2013-10-31 | $-480.74K | $-28.48K | 0.059x | +100.70% |
| 2012-10-31 | $9.74K | $-81.98K | -8.413x | -- |